Physician profile
Wayne Carson Koontz
NPI 1013008036
$744.67
in general payments reported to CMS, 2019-2025
17 companies · $90.13 in 2025
The $90.13 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $146 · 2021: $59.47 · 2022: $115 · 2023: $72.38 · 2024: $63.75 · 2025: $90.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $226.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $178.20 | 2019-2025 | |
| Cranial Technologies, INC | $101.35 | 2019-2024 | Doc Band |
| Merck Sharp & Dohme LLC | $69.37 | 2019-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Tris Pharma INC | $62.59 | 2019-2020 | |
| Sanofi Pasteur INC. | $56.19 | 2020-2025 | |
| Kaleo, INC. | $48.66 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $45.57 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $43.91 | 2019-2020 | |
| Neos Therapeutics, LP | $30.55 | 2020-2022 | |
| Seqirus USA INC | $18.35 | 2023 | Flucelvax Quadrivalent |
| Phadia US INC. | $17.93 | 2022 | |
| Ironshore Pharmaceuticals INC. | $16.95 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.86 | 2024 | Flumist Quadrivalent |
| Sobi, INC | $12.33 | 2019 | |
| Advanced Respiratory, INC | $11.64 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $11.22 | 2020 | |
| American Orthodontics Corporation | $5.00 | 2024 | Master Series, Empower-Metal, LP and Ifit Tubes |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Koontz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.